Annual report pursuant to Section 13 and 15(d)

EQUITY (Details 4)

v3.19.3.a.u2
EQUITY (Details 4) - $ / shares
12 Months Ended
Aug. 31, 2019
Aug. 31, 2018
Aug. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options outstanding 234,000 50,000 0
Weighted Average Remaining Contractual life (in years) 9 years 9 months 11 days 9 years 10 months 24 days  
50,000      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options outstanding 50,000    
Weighted Average Remaining Contractual life (in years) 8 years 11 months 19 days    
Weighted Average Exercise Price $ 10.80    
Options Exercisable Number of shares 21,700    
Options Exercisable Weighted Average Exercise Price $ 10.80    
2,500      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options outstanding 2,500    
Weighted Average Remaining Contractual life (in years) 9 years 10 months 21 days    
Weighted Average Exercise Price $ 3.12    
Options Exercisable Number of shares 2,500    
Options Exercisable Weighted Average Exercise Price $ 3.12    
181,500      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options outstanding 181,500    
Weighted Average Remaining Contractual life (in years) 10 years    
Weighted Average Exercise Price $ 1.99    
Options Exercisable Number of shares 0    
Options Exercisable Weighted Average Exercise Price $ 0